New research presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) annual meeting suggests an association between antimicrobial resistance (AMR) and climate change.
A new study from Centers for Disease Control and Prevention (CDC) and Missouri researchers tested specimens collected from blood donors in northwestern Missouri, and found Heartland virus antibodies in 0.9% of samples. The study appeared yesterday in Emerging Infectious Diseases.
"After controlling for [other] factors, we still find that temperature is a strong predictor of antibiotic resistance."
Italy has now confirmed 14 cases of locally acquired chikungunya, 6 of them in Rome, the World Health Organization (WHO) said in a Sep 15 statement.
In an ongoing multistate Cyclospora outbreak, 96 more patients without a history of international travel who were sick on or after May 1 have been reported to the US Centers for Disease Prevention and Control (CDC), boosting the national total to 347, according to the agency's latest update.
Florida health officials yesterday reported the first sexually transmitted case of Zika virus this year. There is still no evidence, however, of locally transmitted Zika virus by mosquitoes in the state.
Two European countries—Hungary and Romania—reported more highly pathogenic H5N8 avian influenza outbreaks in poultry and wild birds today, and Hong Kong officials confirmed H5N6 in a wild bird found dead in Kowloon, a major urban area.
A recent study in the Journal of Human Lactation showed that pasteurizing breast milk kills both Ebola and Marburg viruses. The research was done at the Mother's Milk Bank of North Texas (MMBNT), and was conducted in the wake of the 2013-2016 Ebola outbreak.
Pigs and llamas appear prone to infection with Middle East respiratory syndrome coronavirus (MERS-CoV), according to researchers who experimentally infected four animal species and reported their findings yesterday in Emerging Infectious Diseases.
Melinta Therapeutics yesterday submitted a New Drug Application (NDA) to the US Food and Drug for the approval of intravenous and oral Baxdela (delafloxacin), an antibiotic for the treatment of bacterial skin and skin structure infections.
